Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Kitakaze

Showing results (61-70 of 433) with videos related to

Pageof 44
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|December 27, 2011
The less embraces the greater in detecting multiple coronary artery diseaseShoji Sanada, Masafumi Kitakaze, Issei Komuro
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 26, 2012
[Classification and feature of ischmic cardiomyopathy]Hiroshi Asanuma, Masanori Asakura, Masafumi Kitakaze
Cardiovascular Drugs and Therapy|August 8, 2024
How Much Is Enough?Yochai Birnbaum, Lisa Kay McClendon, Masafumi Kitakaze
Cardiovascular Drugs and Therapy|June 18, 2024
Acute Hemodynamic Effects of Empagliflozin: Are They Relevant to the Clinical Practice?Faiz Moin Baqai, Masafumi Kitakaze, Yochai Birnbaum
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 8, 2006
[Role of endoplasmic reticulum stress in hypertrophic and failing hearts]Ken-ichiro Okada, Tetsuo Minamino, Masafumi Kitakaze
Cardiovascular Drugs and Therapy|September 13, 2023
Trimetazidine to Reduce Myocardial Fibrosis-Competing Interests with SGLT2 Inhibitors?Tyler B Moran, Masafumi Kitakaze, Yochai Birnbaum
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Anti-diabetic drugs for secondary prevention of cardiovascular disease in mild diabetic and IGT patients: ABC study and PPAR study]Masanori Asakura, Jiyoong Kim, Hiroshi Asanuma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 21, 2019
TRPV2 channel as a possible drug target for the treatment of heart failureYuko Iwata, Shin Ito, Shigeo Wakabayashi, et al.
Diseases (Basel, Switzerland)|December 29, 2017
The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPDMahoto Kato, Kazuo Komamura, Masafumi Kitakaze, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[The trend of research on the mechanism of reperfusion injury]Shoji Sanada, Masatsugu Hori, Koichi Node, et al.
Pageof 44

Showing results (61-70 of 433) with videos related to

Sort By:
Pageof 44
Circulation Journal : Official Journal of the Japanese Circulation Society|December 27, 2011
The less embraces the greater in detecting multiple coronary artery diseaseShoji Sanada, Masafumi Kitakaze, Issei Komuro
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 26, 2012
[Classification and feature of ischmic cardiomyopathy]Hiroshi Asanuma, Masanori Asakura, Masafumi Kitakaze
Cardiovascular Drugs and Therapy|August 8, 2024
How Much Is Enough?Yochai Birnbaum, Lisa Kay McClendon, Masafumi Kitakaze
Cardiovascular Drugs and Therapy|June 18, 2024
Acute Hemodynamic Effects of Empagliflozin: Are They Relevant to the Clinical Practice?Faiz Moin Baqai, Masafumi Kitakaze, Yochai Birnbaum
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 8, 2006
[Role of endoplasmic reticulum stress in hypertrophic and failing hearts]Ken-ichiro Okada, Tetsuo Minamino, Masafumi Kitakaze
Cardiovascular Drugs and Therapy|September 13, 2023
Trimetazidine to Reduce Myocardial Fibrosis-Competing Interests with SGLT2 Inhibitors?Tyler B Moran, Masafumi Kitakaze, Yochai Birnbaum
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Anti-diabetic drugs for secondary prevention of cardiovascular disease in mild diabetic and IGT patients: ABC study and PPAR study]Masanori Asakura, Jiyoong Kim, Hiroshi Asanuma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 21, 2019
TRPV2 channel as a possible drug target for the treatment of heart failureYuko Iwata, Shin Ito, Shigeo Wakabayashi, et al.
Diseases (Basel, Switzerland)|December 29, 2017
The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPDMahoto Kato, Kazuo Komamura, Masafumi Kitakaze, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[The trend of research on the mechanism of reperfusion injury]Shoji Sanada, Masatsugu Hori, Koichi Node, et al.
Pageof 44